RNAi https://www.bioworld.com/rss en-us China’s NMPA clears China Medical System’s CMS-D008 for clinic http://www.bioworld.com/articles/729394 Fri, 06 Mar 2026 08:00:00 -0500 https://www.bioworld.com/articles/729394-chinas-nmpa-clears-china-medical-systems-cms-d008-for-clinic 3D illustration of RNA GSK nabs two Frontier Biotech siRNA assets in $1B deal http://www.bioworld.com/articles/729316 Tue, 03 Mar 2026 12:00:00 -0500 https://www.bioworld.com/articles/729316-gsk-nabs-two-frontier-biotech-sirna-assets-in-1b-deal Illustration of siRNA structure Atrium Tx launches with Avidity's RNA ticker and cardio assets http://www.bioworld.com/articles/729314 Mon, 02 Mar 2026 09:00:00 -0500 https://www.bioworld.com/articles/729314-atrium-tx-launches-with-aviditys-rna-ticker-and-cardio-assets Illustration of human heart with DNA structure background Atrium Tx launches with Avidity's RNA ticker and cardio assets http://www.bioworld.com/articles/729256 Fri, 27 Feb 2026 08:00:00 -0500 https://www.bioworld.com/articles/729256-atrium-tx-launches-with-aviditys-rna-ticker-and-cardio-assets Illustration of human heart with DNA structure background GSK nabs two Frontier Biotech siRNA assets in $1B deal http://www.bioworld.com/articles/729206 Wed, 25 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/729206-gsk-nabs-two-frontier-biotech-sirna-assets-in-1b-deal Illustration of siRNA structure GSK licenses Frontier Biotechnologies’ siRNA therapeutics http://www.bioworld.com/articles/729033 Wed, 25 Feb 2026 08:00:00 -0500 https://www.bioworld.com/articles/729033-gsk-licenses-frontier-biotechnologies-sirna-therapeutics Illustration of kidney with DNA structures Madrigal licenses six Ribo siRNA programs http://www.bioworld.com/articles/728784 Wed, 11 Feb 2026 08:00:00 -0500 https://www.bioworld.com/articles/728784-madrigal-licenses-six-ribo-sirna-programs siRNA bound to mRNA Genentech licenses Sanegene’s RNAi asset in $1.7B deal http://www.bioworld.com/articles/728517 Tue, 03 Feb 2026 08:00:00 -0500 https://www.bioworld.com/articles/728517-genentech-licenses-sanegenes-rnai-asset-in-17b-deal Interfering RNA (RNAi) Repertoire Decodes autoimmunity in $1.92B Eli Lilly deal http://www.bioworld.com/articles/728474 Thu, 29 Jan 2026 12:00:00 -0500 https://www.bioworld.com/articles/728474-repertoire-decodes-autoimmunity-in-192b-eli-lilly-deal T cells Blocking TET3 disrupts OTX2 effects in group 3 medulloblastoma http://www.bioworld.com/articles/728006 Thu, 15 Jan 2026 08:00:00 -0500 https://www.bioworld.com/articles/728006-blocking-tet3-disrupts-otx2-effects-in-group-3-medulloblastoma Microscope with laptop displaying histology image. Sarepta Therapeutics seeks clinical trial clearance for SRP-1005 http://www.bioworld.com/articles/727748 Thu, 08 Jan 2026 08:00:00 -0500 https://www.bioworld.com/articles/727748-sarepta-therapeutics-seeks-clinical-trial-clearance-for-srp-1005 3D illustration of RNA and proteins Obesity rings in New Year with Lilly-Nimbus $1.3B deal, RNAi data http://www.bioworld.com/articles/727696 Tue, 06 Jan 2026 12:00:00 -0500 https://www.bioworld.com/articles/727696-obesity-rings-in-new-year-with-lilly-nimbus-13b-deal-rnai-data Rona Therapeutics seeks clinical trial clearance for RN-5681 http://www.bioworld.com/articles/727265 Thu, 18 Dec 2025 08:00:00 -0500 https://www.bioworld.com/articles/727265-rona-therapeutics-seeks-clinical-trial-clearance-for-rn-5681 Bispecific siRNA knocks down YAP1, WWTR1 with single guide strand http://www.bioworld.com/articles/727134 Mon, 15 Dec 2025 08:00:00 -0500 https://www.bioworld.com/articles/727134-bispecific-sirna-knocks-down-yap1-wwtr1-with-single-guide-strand Liver over digital lens background Peptidream reveals milestone in Alnylam collaboration http://www.bioworld.com/articles/727129 Mon, 15 Dec 2025 08:00:00 -0500 https://www.bioworld.com/articles/727129-peptidream-reveals-milestone-in-alnylam-collaboration Illustration of siRNA structure Junevity raises funds to advance siRNA metabolism program http://www.bioworld.com/articles/726804 Thu, 04 Dec 2025 08:00:00 -0500 https://www.bioworld.com/articles/726804-junevity-raises-funds-to-advance-sirna-metabolism-program Illustration of glucose molecules in a bloodstream Tangram seeks clinical trial clearance for TGM-312 for MASH http://www.bioworld.com/articles/726567 Wed, 26 Nov 2025 08:00:00 -0500 https://www.bioworld.com/articles/726567-tangram-seeks-clinical-trial-clearance-for-tgm-312-for-mash Liver disease Arrowhead’s plozasiran cleared for FCS; Ionis patent duel awaits http://www.bioworld.com/articles/726374 Tue, 18 Nov 2025 15:00:00 -0500 https://www.bioworld.com/articles/726374-arrowheads-plozasiran-cleared-for-fcs-ionis-patent-duel-awaits Redemplo packaging Credit: Arrowhead Pharmaceuticals Inc. City Therapeutics seeks clinical trial clearance for CITY-FXI http://www.bioworld.com/articles/726059 Tue, 11 Nov 2025 08:00:00 -0500 https://www.bioworld.com/articles/726059-city-therapeutics-seeks-clinical-trial-clearance-for-city-fxi Illustration of clot forming in blood vessel Lilly moves deeper into RNAi with $1.2B Sanegene obesity deal http://www.bioworld.com/articles/726150 Tue, 11 Nov 2025 00:00:00 -0500 https://www.bioworld.com/articles/726150-lilly-moves-deeper-into-rnai-with-12b-sanegene-obesity-deal RNA strand Lilly moves deeper into RNAi with $1.2B Sanegene obesity deal http://www.bioworld.com/articles/726099 Mon, 10 Nov 2025 12:00:00 -0500 https://www.bioworld.com/articles/726099-lilly-moves-deeper-into-rnai-with-12b-sanegene-obesity-deal RNA strand Corsera Health seeks clinical trial clearance for COR-1004 http://www.bioworld.com/articles/725625 Tue, 28 Oct 2025 09:00:00 -0400 https://www.bioworld.com/articles/725625-corsera-health-seeks-clinical-trial-clearance-for-cor-1004 Microscope with slide Kalexo enters dyslipidemia fray with preclinical siRNA candidate http://www.bioworld.com/articles/724563 Tue, 23 Sep 2025 11:00:00 -0400 https://www.bioworld.com/articles/724563-kalexo-enters-dyslipidemia-fray-with-preclinical-sirna-candidate Red blood cells in an artery with cholesterol Kalexo enters dyslipidemia fray with preclinical siRNA candidate http://www.bioworld.com/articles/724302 Thu, 18 Sep 2025 11:00:00 -0400 https://www.bioworld.com/articles/724302-kalexo-enters-dyslipidemia-fray-with-preclinical-sirna-candidate Red blood cells in an artery with cholesterol Arrowhead files to begin clinical trials of ARO-MAPT http://www.bioworld.com/articles/724043 Fri, 12 Sep 2025 09:00:00 -0400 https://www.bioworld.com/articles/724043-arrowhead-files-to-begin-clinical-trials-of-aro-mapt Illustration of tau proteins in Alzheimer's disease Novartis taps Argo again, inks potential $5.2B collaboration http://www.bioworld.com/articles/724035 Tue, 09 Sep 2025 11:00:00 -0400 https://www.bioworld.com/articles/724035-novartis-taps-argo-again-inks-potential-52b-collaboration Deal illustration Novartis taps Argo again, inks potential $5.2B collaboration http://www.bioworld.com/articles/723801 Wed, 03 Sep 2025 11:00:00 -0400 https://www.bioworld.com/articles/723801-novartis-taps-argo-again-inks-potential-52b-collaboration Deal illustration Arrowhead and Novartis sign agreement for ARO-SNCA http://www.bioworld.com/articles/723853 Wed, 03 Sep 2025 09:00:00 -0400 https://www.bioworld.com/articles/723853-arrowhead-and-novartis-sign-agreement-for-aro-snca Parkinson's disease illustration showing neurons containing alpha-synuclein Axelyf emerges to tackle RNA delivery, advance autoimmune pipeline http://www.bioworld.com/articles/723626 Tue, 26 Aug 2025 09:00:00 -0400 https://www.bioworld.com/articles/723626-axelyf-emerges-to-tackle-rna-delivery-advance-autoimmune-pipeline 3D illustration of RNA Regeneron's cemdisiran hits phase III endpoints in myasthenia gravis http://www.bioworld.com/articles/723314 Tue, 26 Aug 2025 09:00:00 -0400 https://www.bioworld.com/articles/723314-regenerons-cemdisiran-hits-phase-iii-endpoints-in-myasthenia-gravis Clinical trial virtual display